 | • レポートコード：D0-MOR-AP1182 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、尿管ステントの世界市場について調査・分析した資料で、尿管ステントの市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
The Ureteral Stent Market is expected to register a CAGR of 6.1% during the forecast period owing to the rising burden of the geriatric population and urological disease. The most common urological diseases are benign prostatic hyperplasia (BPH), urinary tract infections (UTIs), and kidney and ureteral stones according to the American Urological Association Foundation. Urinary tract infection is referred to as the infection caused in any part of the urinary system. According to the study published in Microbiology Spectrum, in 2016, around 150 million people are affected by urinary tract infection globally every year and it is one of the most occurring bacterial infections. Also, according to the World Health Organization, in 2018, the incidence of prostate cancer is around 1.3 million. The treatment for these diseases involves the use of ureteral stents which is expected to fuel the ureteral stent market growth.
Key Market Trends
Urinary Tract Infection Segment is Expected to Exibhit a Significant Growth Rate in the Ureteral Stent Market
– The urinary tract infection segment is expected to exibhit a significant growth in the ureteral stents market owing to higher incidence of urinary tract infection and higher adoption of ureteral stents. According to the study published in 2018 by Urology, around 92,000 stents are placed every year in the United States.
– Furthermore, according to the Therapeutics Advances in Urology, 2019, the incidence of urinary tract infection in adult women is around 50% – 60% globally. As the age increases, the risk of acquiring the urinary tract infection is at par and the prevalence rate is almost double in 65 years and above aged women than the rate in the overall population of the female. Hence, these factors are expected to impact positively on the ureteral stents market in this segment.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America expected to hold a major market share in the global ureteral stent market due to the growing burden of diseases related to the kidney. According to the Centre for Disease Control and Prevention data of 2019, in the United States, at least 1 person out of 7 suffers from chronic kidney disease (CKD). Furthermore, almost 37 million population of the United States are affected from CKD and almost 90% of the population is unaware of the situation. Furthermore, according to the Centre for Disease Control and Prevention, chronic kidney disease is commonly found in the older population. The prevalence rate of chronic kidney disease is approximately 38% in the population of 65 years and above. Thus, the rising geriatric population and higher prevalence of chronic kidney disease are expected to be major contributors in the ureteral stents market for this region.
Competitive Landscape
Companies are taking strategic initiatives such as collaborations, mergers, and acquisitions which is expected to drive the market growth. For instance, in 2017, Beckton, Dickinson, and Company acquired C.R. Bard for expansion of its product line which also included ureteral stents. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Uromed, Allium Medical, Coloplast, Beckton, Dickinson, and Company (C.R. Bard, Teleflex Inc.), Boston Scientific, Olympus America, Cook Medical and B. Braun.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Burden of Urological Disorders
4.2.2 Awarness Campaigns Initiated by Government and Other Organization
4.3 Market Restraints
4.3.1 Risk of Infection
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Open-Ended
5.1.2 Close-Ended
5.1.3 Double Pigtail
5.1.4 Multiloop
5.2 By Application
5.2.1 Kidney Stones
5.2.2 Kidney Transplant
5.2.3 Urinary Tract Infection
5.2.4 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Rest of the World
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allium Medical
6.1.2 Becton, Dickinson and Company (C.R. Bard)
6.1.3 B.Braun
6.1.4 Boston Scientific
6.1.5 Coloplast
6.1.6 Cook Medical
6.1.7 Olympus America
6.1.8 Teleflex Inc.
6.1.9 Uromed
7 MARKET OPPORTUNITIES AND FUTURE TRENDS